These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 18492315)

  • 1. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery.
    Mahmood A; Gosling P; Vohra RK
    Br J Surg; 2007 Apr; 94(4):427-33. PubMed ID: 17380548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS).
    Sümpelmann R; Kretz FJ; Gäbler R; Luntzer R; Baroncini S; Osterkorn D; Haeger MC; Osthaus WA
    Paediatr Anaesth; 2008 Oct; 18(10):929-33. PubMed ID: 18647272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?
    Ooi JS; Ramzisham AR; Zamrin MD
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):368-72. PubMed ID: 19713332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hydroxyethyl starch solution on kidney function in surgical intensive care patients].
    Dehne MG; Mühling J; Sablotzki A; Papke G; Kuntzsch U; Hempelmann G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Jun; 32(6):348-54. PubMed ID: 9333329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.
    Mukhtar A; Aboulfetouh F; Obayah G; Salah M; Emam M; Khater Y; Akram R; Hoballah A; Bahaa M; Elmeteini M; Hamza A
    Anesth Analg; 2009 Sep; 109(3):924-30. PubMed ID: 19690268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
    Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
    Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison.
    Bayer O; Reinhart K; Sakr Y; Kabisch B; Kohl M; Riedemann NC; Bauer M; Settmacher U; Hekmat K; Hartog CS
    Crit Care Med; 2011 Jun; 39(6):1335-42. PubMed ID: 21358396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial.
    Kasper SM; Dahlmann H; Mellinghoff H; Ellering J; Baumann M; Buzello W
    Vox Sang; 1998; 75(1):26-31. PubMed ID: 9745150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
    London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
    J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in 1130 children: results of an European prospective multicenter observational postauthorization safety study (PASS).
    Sümpelmann R; Kretz FJ; Luntzer R; de Leeuw TG; Mixa V; Gäbler R; Eich C; Hollmann MW; Osthaus WA
    Paediatr Anaesth; 2012 Apr; 22(4):371-8. PubMed ID: 22211931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
    Israelian LA; Lubnin AIu
    Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
    Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
    Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic and electrolyte effects of hydroxyethyl starches in patients undergoing posterior lumbar interbody fusion using pedicle screws and cages.
    Choi SJ; Ahn HJ; Chung SS; Kim MH; Choi DH; Lee SM; Kang JG; Kim JK
    Spine (Phila Pa 1976); 2010 Apr; 35(7):829-34. PubMed ID: 20072091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of anion gap and strong ion difference caused by hydroxyethyl starch 6% (130/0.42) and gelatin 4% in children.
    Witt L; Osthaus WA; Jüttner B; Heimbucher C; Sümpelmann R
    Paediatr Anaesth; 2008 Oct; 18(10):934-9. PubMed ID: 18811828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG.
    Vanhoonacker J; Ongenae M; Vanoverschelde H; Donadoni R
    Acta Anaesthesiol Belg; 2009; 60(2):91-7. PubMed ID: 19594090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.